Close Menu

This article has been updated to correct the amount of funding being made available to $40 million from the previously reported $16.2 million.

NEW YORK (GenomeWeb) – The National Institutes of Health announced that it will commit as much as $40 million over the next seven years to fund the creation of the National Heart, Lung, and Blood Institute Progenitor Cell Translational Consortium (PCTC), as well as put up $8.2 million for a coordinating center to manage consortium's activities and outreach.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.